TR200002652T2 - The process for the preparation of a tetrapeptide - Google Patents
The process for the preparation of a tetrapeptideInfo
- Publication number
- TR200002652T2 TR200002652T2 TR2000/02652T TR200002652T TR200002652T2 TR 200002652 T2 TR200002652 T2 TR 200002652T2 TR 2000/02652 T TR2000/02652 T TR 2000/02652T TR 200002652 T TR200002652 T TR 200002652T TR 200002652 T2 TR200002652 T2 TR 200002652T2
- Authority
- TR
- Turkey
- Prior art keywords
- preparation
- tetrapeptide
- new
- phe
- tyr
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000013067 intermediate product Substances 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bu bulusta, asagidaki (I) formülüne sahip: bir peptit olan H-Tyr-D-Ala-Phe (pF)-Phe-NH2 yapisindaki tetrapeptitin ya da bunun ilaç sanayiinde kullanilmaya uygun bir tuzunun hazirlanmasina yönelik yeni ve iyilestirilmis bir islemin yani sira,bunun hazirlanmasinda kullanilan yeni ara ürünler anlatilmistir. Yeni islem, büyük ölçekli üretim için uygundur.In this invention, as well as a new and improved process for the preparation of the following formula (I): the tetrapeptide of the peptide H-Tyr-D-Ala-Phe (pF) -Phe-NH2 or a salt thereof suitable for use in the pharmaceutical industry, new intermediate products used in its preparation are described. The new process is suitable for large-scale production.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800865A SE9800865D0 (en) | 1998-03-16 | 1998-03-16 | New Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200002652T2 true TR200002652T2 (en) | 2000-11-21 |
Family
ID=20410566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/02652T TR200002652T2 (en) | 1998-03-16 | 1999-03-16 | The process for the preparation of a tetrapeptide |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1062231A1 (en) |
| JP (1) | JP2002506880A (en) |
| KR (1) | KR20010041888A (en) |
| CN (1) | CN1300293A (en) |
| AU (1) | AU2968899A (en) |
| BR (1) | BR9908765A (en) |
| CA (1) | CA2323678A1 (en) |
| EE (1) | EE200000540A (en) |
| HU (1) | HUP0102877A3 (en) |
| ID (1) | ID26938A (en) |
| IL (1) | IL138244A0 (en) |
| IS (1) | IS5612A (en) |
| NO (1) | NO20004613L (en) |
| PL (1) | PL343277A1 (en) |
| SE (1) | SE9800865D0 (en) |
| SK (1) | SK13442000A3 (en) |
| TR (1) | TR200002652T2 (en) |
| WO (1) | WO1999047548A1 (en) |
| ZA (1) | ZA200004376B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903291D0 (en) * | 1999-09-15 | 1999-09-15 | Astra Ab | New process |
| CA2707733C (en) * | 2007-12-13 | 2018-01-02 | Cytogel, Llc | Advantageous salts of mu-opiate receptor peptides |
| CN104478993B (en) * | 2013-06-20 | 2017-10-10 | 重庆理工大学 | A kind of non-protein amino acid antibacterial peptide and its application |
| CN104371002B (en) * | 2013-06-20 | 2017-10-10 | 重庆理工大学 | A kind of non-protein amino acid antibacterial peptide and its application |
| CN103319568B (en) * | 2013-06-20 | 2015-01-21 | 重庆理工大学 | A kind of non-protein amino acid antimicrobial peptide and its application |
| CN104783298A (en) * | 2015-03-24 | 2015-07-22 | 湖州珍贝羊绒制品有限公司 | Preparation and application of biological sterilizing composition and nanoemulsion thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9503924D0 (en) * | 1995-08-18 | 1995-11-07 | Astra Ab | Novel opioid peptides |
| GB9516994D0 (en) * | 1995-08-18 | 1995-10-18 | Iaf Biochem Int | Solution synthesis of peripheral acting analgestic opioid tetrapeptides |
-
1998
- 1998-03-16 SE SE9800865A patent/SE9800865D0/en unknown
-
1999
- 1999-03-16 BR BR9908765-0A patent/BR9908765A/en not_active IP Right Cessation
- 1999-03-16 PL PL99343277A patent/PL343277A1/en not_active Application Discontinuation
- 1999-03-16 EE EEP200000540A patent/EE200000540A/en unknown
- 1999-03-16 SK SK1344-2000A patent/SK13442000A3/en unknown
- 1999-03-16 AU AU29688/99A patent/AU2968899A/en not_active Abandoned
- 1999-03-16 IL IL13824499A patent/IL138244A0/en unknown
- 1999-03-16 HU HU0102877A patent/HUP0102877A3/en unknown
- 1999-03-16 ID IDW20001952A patent/ID26938A/en unknown
- 1999-03-16 KR KR1020007010189A patent/KR20010041888A/en not_active Withdrawn
- 1999-03-16 WO PCT/SE1999/000414 patent/WO1999047548A1/en not_active Ceased
- 1999-03-16 TR TR2000/02652T patent/TR200002652T2/en unknown
- 1999-03-16 EP EP99910934A patent/EP1062231A1/en not_active Withdrawn
- 1999-03-16 CN CN99806071A patent/CN1300293A/en active Pending
- 1999-03-16 JP JP2000536740A patent/JP2002506880A/en active Pending
- 1999-03-16 CA CA002323678A patent/CA2323678A1/en not_active Abandoned
-
2000
- 2000-08-24 ZA ZA200004376A patent/ZA200004376B/en unknown
- 2000-08-30 IS IS5612A patent/IS5612A/en unknown
- 2000-09-15 NO NO20004613A patent/NO20004613L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9800865D0 (en) | 1998-03-16 |
| HUP0102877A2 (en) | 2002-01-28 |
| IS5612A (en) | 2000-08-30 |
| NO20004613L (en) | 2000-10-30 |
| EE200000540A (en) | 2002-02-15 |
| SK13442000A3 (en) | 2001-04-09 |
| BR9908765A (en) | 2000-11-07 |
| ZA200004376B (en) | 2001-10-31 |
| JP2002506880A (en) | 2002-03-05 |
| WO1999047548A1 (en) | 1999-09-23 |
| HUP0102877A3 (en) | 2002-02-28 |
| PL343277A1 (en) | 2001-08-13 |
| CA2323678A1 (en) | 1999-09-23 |
| EP1062231A1 (en) | 2000-12-27 |
| CN1300293A (en) | 2001-06-20 |
| KR20010041888A (en) | 2001-05-25 |
| NO20004613D0 (en) | 2000-09-15 |
| IL138244A0 (en) | 2001-10-31 |
| ID26938A (en) | 2001-02-22 |
| AU2968899A (en) | 1999-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200100299T2 (en) | Therapeutic biaryl derivatives. | |
| PT1086124E (en) | NEW CYCLOSPORINS | |
| TR200200768T2 (en) | New quinuclide derivatives and drug compositions containing it | |
| ATE263157T1 (en) | NEMATICIDE TRIFLUORBUTENE | |
| TR200101961T2 (en) | 1,2-ring quinoline derivatives | |
| DE60204452D1 (en) | [1,5] pyridine derivatives | |
| TR200101899T2 (en) | Thrombin inhibitors. | |
| PT923570E (en) | AMIDES OF PYRIDYL-ALCENOIC AND PYRIDYL-ALCINIC ACIDS AS CITOSTATIC AND IMMUNOSUPRESSIVE AGENTS | |
| SE9904505D0 (en) | Novel compounds | |
| HUP0102579A2 (en) | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use | |
| TR199902082T2 (en) | Pirazin bile�ikleri. | |
| TR200101412T2 (en) | New compounds. | |
| TR200200785T2 (en) | 8-Phenyl-6,9-dihydro- [1,2,4] triazolo [3,4-i] purin-5-one derivatives | |
| HUP9800688A2 (en) | Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them | |
| NO20015226L (en) | Tri-aryl acid derivatives such as PPAR receptor ligands, pharmaceutical composition comprising the same and use of the same for the preparation of drug. | |
| SE9903291D0 (en) | New process | |
| TR200002542T2 (en) | Meta-azacyclic amino benzoic acid compounds and their derivatives as integrin antagonists | |
| TR200201168T2 (en) | CGRP-Antagonists-drugs containing new cyclopropanes and production methods. | |
| NO971625L (en) | Novel peptides with immunomodulatory effects | |
| TR199800608A2 (en) | Propanolamin t�revleri, bunlar�n �retim usul�. | |
| PT1060175E (en) | TRIPTASE INHIBITORS | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| TR200002652T2 (en) | The process for the preparation of a tetrapeptide | |
| MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
| CY1112050T1 (en) | NEW 2-HOLOGENIFIED PRODUCTS OF 5-0- DESESOAMINYLYLTRONOLIDE A, THEIR PROCEDURE AND THEIR APPLICATION AS MEDICINES |